Article
Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologies
2022-02-28
Abstract excerpt
<h4>Introduction</h4> In Alzheimer’s disease clinical research, glial fibrillary acidic protein (GFAP) released into the cerebrospinal fluid and blood is widely measured and perceived as a biomarker of reactive astrogliosis. However, it was demonstrated that GFAP levels differ in individuals presenting with amyloid-β (Aβ) or tau pathology. The molecular underpinnings behind this specificity are unexplored. Here w...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6d07a1bd-fb8c-5417-ad03-e9c02be6d9c9
- DOI
- 10.1101/2022.02.25.481812
